Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Bank Pictet & Cie Europe AG

Bank Pictet & Cie Europe AG reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 190,086 shares of the medical equipment provider’s stock after selling 6,347 shares during the quarter. Intuitive Surgical comprises approximately 2.2% of Bank Pictet & Cie Europe AG’s portfolio, making the stock its 11th largest holding. Bank Pictet & Cie Europe AG owned about 0.05% of Intuitive Surgical worth $93,384,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Creekmur Asset Management LLC increased its position in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new position in Intuitive Surgical during the second quarter worth approximately $26,000. Delos Wealth Advisors LLC lifted its stake in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the last quarter. Godsey & Gibb Inc. lifted its stake in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the last quarter. Finally, LRI Investments LLC acquired a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have commented on ISRG shares. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. Truist Financial boosted their price target on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday, October 14th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday. Mizuho boosted their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, BTIG Research set a $535.00 price target on Intuitive Surgical in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $517.50 on Wednesday. The firm has a market capitalization of $183.56 billion, a price-to-earnings ratio of 93.41, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39. The business’s 50 day simple moving average is $485.88 and its 200-day simple moving average is $440.46. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $523.34.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 1,413 shares of the firm’s stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $438.60, for a total transaction of $619,741.80. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,414,931.60. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 51,455 shares of company stock valued at $24,911,155. 0.90% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.